Huijun Lu
85 Wujin Road
Shanghai, 200080, China
Shanghai, 200080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
miR-200b regulates breast cancer cell proliferation and invasion by targeting radixin.
Journal: Experimental and therapeutic medicine
Published: December 07, 2018
Effects of various treatment approaches for treatment efficacy for late stage breast cancer and expression level of TIMP-1 and MMP-9.
Journal: Cancer biomarkers : section A of Disease markers
Published: July 17, 2018
A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers.
Journal: Scientific reports
Published: January 26, 2016
Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 07, 2015
Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 18, 2015
Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 18, 2014
Zinc-α-2-glycoprotein: a candidate biomarker for colon cancer diagnosis in Chinese population.
Journal: International journal of molecular sciences
Published: November 12, 2014
Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
Journal: Journal of gastroenterology and hepatology
Published: September 12, 2014
Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.
Journal: International journal of clinical and experimental pathology
Published: August 21, 2014
Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer.
Journal: International journal of clinical and experimental pathology
Published: June 27, 2014
PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy.
Journal: Oncotarget
Published: June 09, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026